Page 306 - AIDSBK23C
P. 306

Page 306



               99      Hemelaar J, Gouws E, Ghys PD, Osmanov S; WHO-UNAIDS Network for HIV Isolation
                       and Characterisation. Global trends in molecular epidemiology of HIV-1 during 2000-
                       2007. AIDS. 2011;25(5):679-689.

               100     Essex M. Human immunodeficiency viruses in the developing world. Adv Virus Res.
                       1999;53:71-88.

               101     de Silva TI, Cotten M, Rowland-Jones SL. HIV-2: the forgotten AIDS virus. Trends
                       Microbiol. 2008;16:588-595.

               102     Campbell-Yesufu OT, Gandhi RT. Update on human immunodeficiency virus (HIV)-2
                       infection. Clin Infect Dis. 2011;52(6):780-787.

               103     Duvall MG, Jaye A, Dong T, et al. Maintenance of HIV-specific CD4+ T cell help
                       distinguishes HIV-2 from HIV-1 infection. J Immunol. 2006;176:6973-6981.

               104     Gao F, Yue L, Robertson DL, Hill SC, Hui H, Biggar RJ, Neequaye AE, et al. Genetic
                       diversity of human immunodeficiency virus type 1: evidence for distinct sequence
                       subtypes with differences in virus biology. J Virol. 1994;68:7433-7447.

               105     Markovitz DM. Infection with the human immunodeficiency virus type 2. Ann Intern
                       Med. 1993;118:211-218.

               106     Gurtler LG, Zekeng L, Tsague JM, et al. HIV-1 subtype O: epidemiology, pathogenesis,
                       diagnosis, and perspectives of the evolution of HIV. Arch Virol Suppl. 1996;11:195-202.

               107     Casoli C, Pilotti E, Bertazzoni U. Molecular and cellular interactions of HIV-1/HTLV
                       coinfection and impact on AIDS progression. AIDS Rev. 2007;9:140-149.

               108     Ferreira OC Jr, Planelles V, Rosenblatt JD. Human T-cell leukemia viruses:
                       epidemiology, biology, and pathogenesis. Blood Rev. 1997;11:91-104.

               109     Andersson S, Thorstensson R, Ramirez KG, Krook A, von Sydow M, Dias F, Biberfeld
                       G. Comparative evaluation of 14 immunoassays for detection of antibodies to the human
                       T-lymphotropic virus types I and II using panels of sera from Sweden and West Africa.
                       Transfusion. 1999;39:845-851.

               110     Cooper SA, van der Loeff MS, Taylor GP. The neurology of HTLV-1 infection. Pract
                       Neurol. 2009;9:16-26.

               111     Vandamme AM, Bertazzoni U, Salemi M. Evolutionary strategies of human T-cell
                       lymphotropic virus type II. Gene. 2000;261:171-180.

               112     Araujo A, Hall WW. Human T-lymphotropic virus type II and neurological disease. Ann
                       Neurol. 2004;56(1):10-19.
   301   302   303   304   305   306   307   308   309   310   311